|
Name |
Linoleoyl chloride
|
Molecular Formula | C18H31ClO | |
IUPAC Name* |
(9Z,12Z)-octadeca-9,12-dienoyl chloride
|
|
SMILES |
CCCCC/C=C\C/C=C\CCCCCCCC(=O)Cl
|
|
InChI |
InChI=1S/C18H31ClO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3/b7-6-,10-9-
|
|
InChIKey |
FBWMYSQUTZRHAT-HZJYTTRNSA-N
|
|
Synonyms |
Linoleoyl chloride; Linoleic acid chloride; 7459-33-8; (9Z,12Z)-Octadeca-9,12-dienoyl chloride; Lineoleoyl chloride; LINOLEOYLCHLORIDE; 9,12-Octadecadienoyl chloride, (Z,Z)-; R0E0WI3SP3; NSC-162219; EINECS 231-233-8; MFCD00151403; linolic acid chloride; NSC 162219; UNII-R0E0WI3SP3; SCHEMBL118170; DTXSID30880877; ZINC4556742; Delta 9-12 Octadecadienoyl chloride; Linoleoyl chloride, >=99%, liquid; (Z,Z)-9,12-octadecadienoyl chloride; AKOS024386304; 9,12-Octadecadienoylchloride,(9Z,12Z)-; L0113; (9E,12E)-9,12-Octadecadienoyl chloride #; T72900; W-110221
|
|
CAS | 7459-33-8 | |
PubChem CID | 9817754 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 298.9 | ALogp: | 7.6 |
HBD: | 0 | HBA: | 1 |
Rotatable Bonds: | 14 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 17.1 | Aromatic Rings: | 0 |
Heavy Atoms: | 20 | QED Weighted: | 0.203 |
Caco-2 Permeability: | -4.827 | MDCK Permeability: | 0.00003000 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.022 | 20% Bioavailability (F20%): | 0.999 |
30% Bioavailability (F30%): | 1 |
Blood-Brain-Barrier Penetration (BBB): | 0.516 | Plasma Protein Binding (PPB): | 98.53% |
Volume Distribution (VD): | 3.093 | Fu: | 0.88% |
CYP1A2-inhibitor: | 0.437 | CYP1A2-substrate: | 0.455 |
CYP2C19-inhibitor: | 0.504 | CYP2C19-substrate: | 0.073 |
CYP2C9-inhibitor: | 0.423 | CYP2C9-substrate: | 0.969 |
CYP2D6-inhibitor: | 0.326 | CYP2D6-substrate: | 0.912 |
CYP3A4-inhibitor: | 0.65 | CYP3A4-substrate: | 0.12 |
Clearance (CL): | 5.123 | Half-life (T1/2): | 0.917 |
hERG Blockers: | 0.165 | Human Hepatotoxicity (H-HT): | 0.242 |
Drug-inuced Liver Injury (DILI): | 0.29 | AMES Toxicity: | 0.982 |
Rat Oral Acute Toxicity: | 0.024 | Maximum Recommended Daily Dose: | 0.104 |
Skin Sensitization: | 0.964 | Carcinogencity: | 0.897 |
Eye Corrosion: | 0.98 | Eye Irritation: | 0.964 |
Respiratory Toxicity: | 0.964 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001584 | 0.839 | D0O1TC | 0.714 | ||||
ENC001535 | 0.839 | D0UE9X | 0.629 | ||||
ENC001660 | 0.800 | D0OR6A | 0.605 | ||||
ENC001605 | 0.800 | D0O1PH | 0.557 | ||||
ENC001583 | 0.765 | D07ILQ | 0.376 | ||||
ENC001699 | 0.754 | D09SRR | 0.375 | ||||
ENC001714 | 0.732 | D0Z5BC | 0.368 | ||||
ENC001711 | 0.732 | D0XN8C | 0.365 | ||||
ENC001845 | 0.703 | D05ATI | 0.351 | ||||
ENC001589 | 0.688 | D0H2YX | 0.346 |